Glucose Response, Excursions And Treatment (GREAT) Study

NCT02506296 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: DPPIV inhibitor -
DEVICE: Continuous glucose monitoring system.

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Collaborators

[object Object]